Hurdle, a pioneer in diagnostic testing, and the Consumer Health division of Bayer have launched a strategic partnership to advance consumer innovations in the emerging...
Tafinlar and Mekinist led to a 56% overall response rate in children with BM-HGGUniversity College London (UCL) and Great Ormond Street Hospital (GOSH) have published...
Around 3,000 new cases of mesothelioma are diagnosed in the US every yearSeveral researchers, including those from King's College London (KCL), have detailed how a...
The U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Ogsiveo is the first...
The IRP will bring life-saving medicines to UK patients from 1 January 2024The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the launch of...
The findings could benefit patients living with neurodegenerative conditionsA new study published in the journal Neurology has suggested that as the hippocampus area of the...
ADP101 is an oral immunotherapy to treat multi-food and single-food allergiesAlladapt Immunotherapeutics has announced that its investigational multi-food oral immunotherapy (mOIT), ADP101, has received Fast...
Both companies will use their platforms to accelerate drug discovery and developmentGenentech has announced it has entered into a multi-year strategic artificial intelligence (AI) research...